Delivery Order SPE2DR25D2206-SPE2DR26F9EG7
Award Date 12/4/25
Potential Completion Date 12/26/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $37,975.20 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials, a specialized pharmaceutical product. The contract, issued on December 2, 2025, with an ultimate completion date of December 23, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Padcev 20 mg vials, a chemotherapy medication used in cancer treatment. This competitively awarded, firm fixed-price delivery order has a ceiling value of $15,579.68 and is scheduled for completion by December 10, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,719 on July 28, 2025, for the supply of Padcev 30 mg vials. This firm fixed-price delivery order, which is expected to be completed by August 18, 2025, was issued without a set-aside designation, indicating it was competitively awarded. The contract is performed at the awardee's Corporate Office location in Conshohocken, PA and is funded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $27,719 to AmerisourceBergen Drug Corp for 30 mg vials of Padcev, a oncology treatment, with performance at the company's Conshohocken, Pennsylvania facility. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025. As a non-set-aside contract, the award reflects AmerisourceBergen's demonstrated capability to compete successfully in federal pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for PADCEV 20 MG vials valued at $3,695.90 by the Defense Logistics Agency (DLA). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with no set-aside designation applied. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems, leveraging the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on September 15, 2025, for Padcev 30 mg vials with a ceiling value of $83,157.00. This firm fixed price contract, issued by the Defense Logistics Agency's Medical Supply Chain, represents a competitively awarded procurement with no set-aside designation and is scheduled for completion by October 6, 2025. The contract is structured as a child delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,211.60 for PADCEV 30 mg vials on December 2, 2025, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is to be performed at AmerisourceBergen's corporate office location...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of PADCEV (ado-trastuzumab vedotin) 20 mg vials, with a ceiling value of $11,684.76. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and was competitively awarded through an open procurement...